Special Issue "Recent Advances in Microneedle-Mediated Drug Delivery, 2nd Edition"

A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".

Deadline for manuscript submissions: 8 February 2024 | Viewed by 254

Special Issue Editors

School of Pharmceutical Science, Sun Yat-Sen University, Guangzhou 510006, China
Interests: microneedles; pulmonary drug delivery; novel drug-delivery systems
Special Issues, Collections and Topics in MDPI journals
College of Pharmacy, Jinan University, Guangzhou 510006, China
Interests: dissolving microneedles for transdermal drug delivery; porous carriers for drug delivery; immunotherapy; phototherapy; nanomedicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Microneedles (MNs) have become a new generation of topical delivery systems, which are revolutionizing the landscape of transdermal drug delivery. In general, MNs are micrometer-sized needles arranged orderly on a base, and their lengths usually range from 25 to 2000 μm. Research has proved that the MNs can penetrate the stratum corneum and create an array of temporary microchannels in the skin, which can significantly increase transdermal drug permeation. In addition, MNs are designed to penetrate into the viable epidermis and upper dermis, to avoid contact with the nerve fibers and blood vessels that reside primarily in the deep dermal layer, resulting in minimal pain and invasiveness. With great patient compliance and efficiency in drug delivery, MNs could offer unlimited potential for the transdermal delivery of various therapeutic agents such as small molecules, biological macromolecules, vaccines, and even nanoparticles.

The theme of this Special Issue deals with all aspects of microneedle-mediated drug-delivery systems including the design, fabrication, and characterization of microneedle formulations, and their use as strategies for the prevention or treatment of medical conditions such as cancer, infection, diabetes, and dermatological diseases and for vaccinations.

Dr. Xin Pan
Dr. Guilan Quan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • transdermal drug delivery
  • microneedle-mediated drug delivery
  • dissolving microneedles

Related Special Issue

Published Papers

This special issue is now open for submission.
Back to TopTop